-
July 19, 2002 Questioning $1 Million Fee in a Needle DealQuestioning $1 Million Fee in a Needle Deal New York Times released an article today...
-
July 19, 2002 CEOcast Interview Tom ShawCEOcast Interview Tom Shaw CEOcast today interviewed Tom Shaw, Chairman, President and CEO of Retractable...
-
July 17, 2002 Investrend Update: RVP Well Capitalized for Future GrowthInvestrend Update: RVP Well Capitalized for Future Growth Investrend Research recently released an update note...
-
July 11, 2002 Retractable Technologies Bolsters Financial Position Through Major Balance Sheet RestructuringRetractable Technologies Bolsters Financial Position Through Major Balance Sheet Restructuring LITTLE ELM, Texas--In a move...
-
July 9, 2002 Investrend Update Available for RVPInvestrend Update Available for RVP Investrend has released a July update on Retractable Technologies Inc.,...
-
June 28, 2002 Retractable Technologies Signs Agreements to Market VanishPoint® Safety Needle Devices to the Benelux Countries, Denmark and SwedenRetractable Technologies Signs Agreements to Market VanishPoint® Safety Needle Devices to the Benelux Countries, Denmark...
-
June 24, 2002 Retractable Technologies Signs Agreement to Produce VanishPoint® Safety Syringes in China for Global MarketRetractable Technologies Signs Agreement to Produce VanishPoint® Safety Syringes in China for Global Market LITTLE...
-
June 7, 2002 Letter to Shareholders Dated May 31,2002Letter to Shareholders Dated May 31, 2002 The attached Adobe PDF document is a letter...
-
June 7, 2002 New York Times: A Mission to Save Money, a Record of OtherwiseNew York Times: A Mission to Save Money, a Record of Otherwise The New York...
-
May 22, 2002 Centers for Disease Control Selects VanishPoint (R) Safety Needle Devices for Anthrax Vaccine StudyCenters for Disease Control Selects VanishPoint (R) Safety Needle Devices for Anthrax Vaccine Study LITTLE...
